HAI2024 Book - Flipbook - Page 9
115 Deep learning-based partial
volume correction for tau PET
imaging.........................................385
124 Tau-PET Overlap Index;
associations with Braak Stage and
quantitative NFT measurements 409
Schultz, Stephanie..................................... 387
Coomans, Emma ....................................... 412
116 Plasma levels of an N-terminal
tau fragment predict core AD and
neurodegenerative biomarkers in
autosomal dominant Alzheimer’s
disease ......................................... 387
125 Tau-PET spatial extent for
predicting cognitive decline within
tau-positive individuals ............... 412
Franzmeier, Nicolai ................................... 392
117 Increased CSF GAP-43 is
associated with accelerated tau
accumulation and spread in
Alzheimer’s disease .....................392
Huang, Shao-Yi .......................................... 396
118 Investigating the impacts of tau
status in Alzheimer’s disease by
using [18F]Florzolotau tau cutoff 396
Lin, Jyh-Ruei ............................................. 398
119 Study of reference regions in
the quantitation of [18F]Florzolotau
tau PET imaging ...........................398
Gogola, Alexandra..................................... 400
120 Assessing the efficacy of
BETTH-derived tau thresholds to
predict cognitive decline ............ 400
Gogola, Alexandra......................................403
121 Assessing the correlations
between imaging and plasma
biomarkers within the AT(N)
framework .................................. 403
Povala, Guilherme ......................................406
122 The effect of microglial
activation on brain atrophy across
the Alzheimer's disease continuum
..................................................... 406
Aumont, Etienne ........................................408
123 Disentangling the relationships
between tau-PET, amyloid-β-PET,
hippocampal subfield volumes, and
memory: a longitudinal study ..... 408
Lowe, Val...................................................409
Li, Jinghang .............................................. 416
126 Association of sex and cerebral
beta-amyloid with cortical gray
matter brain age in cognitively
impaired older adults ................... 416
Edison, Paul.............................................. 420
127 Will cerebral glucose
metabolism measured using
[18F]FDG PET substitute tau PET in
clinical studies? .......................... 420
Edison, Paul............................................... 421
128 CSF sTREM2 is associated with
neuroprotective microglial states
early in Alzheimer’s disease and
deleterious effects later in the
disease trajectory ........................ 421
Jutten, Roos ..............................................422
129 The Mobile Toolbox for
assessing cognition remotely:
associations with amyloid and tau
deposition in cognitively unimpaired
older adults ................................. 422
Cody, Karly ................................................ 425
130 Characterizing multi-site
harmonized amyloid and tau PET
across the Alzheimer’s continuum
..................................................... 425
Cody, Karly ................................................ 428
131 Characterization of tau PET
accumulation relative to duration of
entorhinal tau positivity .............. 428
Lois Gomez, Cristina .................................. 432
132 Harmonization of multi-scanner
PET data with ComBat: application
to 18F-AV1451 data acquired on a
Siemens ECAT HR+ PET and a GE
Discovery MI PET/CT Scanner .... 432
Burton, Courtney ....................................... 435
HAI2024 - 9